Blue Water Vaccines Announces Signing of Sponsored Research Agreement with Cincinnati Children’s Hospital Medical Center for S&P Vaccine Platform Development
July 20, 2022 14:00 ET
|
Blue Water Vaccines Inc.
CINCINNATI, July 20, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address...
Blue Water Vaccines Announces Publication in Nano Research Supporting Novel S&P Vaccine Platform Versatility
March 22, 2022 07:00 ET
|
Blue Water Vaccines Inc.
Blue Water Vaccines has exclusive, global licensing rights to Cincinnati Children’s Hospital Medical Center’s novel virus-like particle (VLP) vaccine platform.The data supports BWV’s ongoing...
Blue Water Vaccines Announces Closing of Initial Public Offering
February 23, 2022 16:51 ET
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the closing...
American Health Council Names DonnaMaria E. Cortezzo, MD to Physician Board
April 26, 2017 12:11 ET
|
American Health Council
NEW YORK, April 26, 2017 (GLOBE NEWSWIRE) -- Dr. DonnaMaria E. Cortezzo, Attending Neonatologist and Pediatric Palliative Care Provider at Cincinnati Children’s Hospital Medical Center and Assistant...
MRI Interventions' ClearPoint System Utilized at Cincinnati Children's Hospital for Asleep Deep Brain Stimulation Procedure in Pediatric Dystonia
September 26, 2013 08:00 ET
|
ClearPoint Neuro, Inc.
IRVINE, Calif., Sept. 26, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) announced today that its ClearPoint® Neuro Intervention System for real-time MRI-guided navigation in...